C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 2,664 | 3,759 | 2,854 | 6,754 | 13,834 |
| Gross Profit | 2,664 | 3,759 | 2,854 | 6,754 | 13,834 |
| Operating Expenses | 40,232 | 39,987 | 41,147 | 39,242 | 41,218 |
| Operating Income | -37,568 | -36,228 | -38,293 | -32,488 | -27,384 |
| Interest Expense | 600 | 606 | 601 | 554 | 534 |
| Other Income | 2,246 | 2,054 | 1,709 | 1,084 | 506 |
| Pre-tax Income | -35,922 | -34,780 | -37,185 | -31,958 | -27,412 |
| Net Income Continuous | -35,922 | -34,780 | -37,185 | -31,958 | -27,412 |
| Net Income | $-35,922 | $-34,780 | $-37,185 | $-31,958 | $-27,412 |
| EPS Basic Total Ops | -0.73 | -0.71 | -0.76 | -0.65 | -0.56 |
| EPS Basic Continuous Ops | -0.73 | -0.71 | -0.76 | -0.65 | -0.56 |
| EPS Diluted Total Ops | -0.73 | -0.71 | -0.76 | -0.65 | -0.56 |
| EPS Diluted Continuous Ops | -0.73 | -0.71 | -0.76 | -0.65 | -0.56 |
| EBITDA(a) | $-38,010 | $-36,153 | $-37,997 | $-31,857 | $-26,353 |